These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14563997)

  • 21. Nuclear receptors in macrophages: a link between metabolism and inflammation.
    Szanto A; Roszer T
    FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
    Tham DM; Martin-McNulty B; Wang YX; Wilson DW; Vergona R; Sullivan ME; Dole W; Rutledge JC
    Physiol Genomics; 2002 Oct; 11(1):21-30. PubMed ID: 12361987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of green tea polyphenols on the genes with atherosclerotic potential.
    Kaul D; Sikand K; Shukla AR
    Phytother Res; 2004 Feb; 18(2):177-9. PubMed ID: 15022174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summon SUMO to wrestle with inflammation.
    Liu B; Shuai K
    Mol Cell; 2009 Sep; 35(6):731-2. PubMed ID: 19782020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.
    Hansen MK; Connolly TM
    Curr Opin Investig Drugs; 2008 Mar; 9(3):247-55. PubMed ID: 18311660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes.
    Hanriot D; Bello G; Ropars A; Seguin-Devaux C; Poitevin G; Grosjean S; Latger-Cannard V; Devaux Y; Zannad F; Regnault V; Lacolley P; Mertes PM; Hess K; Longrois D
    Thromb Haemost; 2008 Mar; 99(3):558-69. PubMed ID: 18327405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages.
    Fontaine C; Rigamonti E; Nohara A; Gervois P; Teissier E; Fruchart JC; Staels B; Chinetti-Gbaguidi G
    Circ Res; 2007 Jul; 101(1):40-9. PubMed ID: 17540978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-atherosclerotic effects of PPAR gamma ligands].
    Wakino S
    Nihon Rinsho; 2004 Jan; 62(1):180-6. PubMed ID: 14737851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRRAP as a hepatic coactivator of LXR and FXR function.
    Unno A; Takada I; Takezawa S; Oishi H; Baba A; Shimizu T; Tokita A; Yanagisawa J; Kato S
    Biochem Biophys Res Commun; 2005 Feb; 327(3):933-8. PubMed ID: 15649435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic effect of vitamin 'C' and statins within human mononuclear cells involved in atherogenic process.
    Kaul D; Baba MI
    Eur J Clin Nutr; 2005 Aug; 59(8):978-81. PubMed ID: 15970944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of macrophage liver X receptors as inhibitors of atherosclerosis.
    Tangirala RK; Bischoff ED; Joseph SB; Wagner BL; Walczak R; Laffitte BA; Daige CL; Thomas D; Heyman RA; Mangelsdorf DJ; Wang X; Lusis AJ; Tontonoz P; Schulman IG
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11896-901. PubMed ID: 12193651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of lipid metabolism by liver X-activated receptors].
    Wu J; Zhang ZW; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):69-72. PubMed ID: 15127605
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptors and atherosclerosis.
    Lala DS
    IDrugs; 2004 Jun; 7(6):563-9. PubMed ID: 15197661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis.
    Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
    Trends Pharmacol Sci; 2003 Oct; 24(10):530-4. PubMed ID: 14559405
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetics and molecular biology.
    Garcia-Otin AL; Zakin MM
    Curr Opin Lipidol; 2003 Oct; 14(5):531-5. PubMed ID: 14501592
    [No Abstract]   [Full Text] [Related]  

  • 38. The liver X receptor gene team: potential new players in atherosclerosis.
    Repa JJ; Mangelsdorf DJ
    Nat Med; 2002 Nov; 8(11):1243-8. PubMed ID: 12411951
    [No Abstract]   [Full Text] [Related]  

  • 39. The PPARs 2001: it's not over 'til the fat lady sings. 4-10 February 2001.
    Forman BM
    Trends Mol Med; 2001 Aug; 7(8):331-2. PubMed ID: 11516973
    [No Abstract]   [Full Text] [Related]  

  • 40. What are nuclear receptor ligands?
    Sladek FM
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):3-13. PubMed ID: 20615454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.